Alcoholism Treated With Vivitrol-Assisted Recovery Midwest
Alcoholism treated with Vivitrol-Assisted Recovery Midwest – Assisted Recovery Alcholol and Drug Rehab Channel 5 Cover Story on Vivitrol ARCA Midwest (Assisted Recovery Centers of America) is one of the first facilities in St. Louis to offer VIVITROL®, an injectable form of naltrexone, to treat alcohol dependence. With VIVITROL, you don’t have to take medicine for your alcohol dependence every day. That means more time for you to focus on your successes, your goals, and your recovery. Proven Support for Recovery: Safe, proven medications virtually eliminate withdrawal symptoms and cravings, greatly improving treatment success. Alcohol and narcotics damage the brains pleasure system, producing the overwhelming cravings of addiction. This chemical imbalance can be corrected with medication. FDA-approved drugs such as Suboxone® (buprenorphine) relieve withdrawal symptoms, while Vivitrol®, ReVia® (naltrexone) control cravings. Other promising medications include Zofran® (ondansetron) and Topamax® (topiramate). Unlike older alternatives, these treatments are non-mood altering, non-addictive and have few side effects. Most patients take anti-craving medications for three to six months and continue counseling for up to one year. Freed from physical discomforts, you can focus on relapse-prevention counseling and long-term recovery. Best of all, you can undertake this treatment on an outpatient basis. Anti-craving medications can generally be taken along with treatments for mental health issues such as depression, anxiety, and post …
Morocco activists slam African migrant treatment
Filed under: drug treatment news stories
Last week, the pro-regime weekly magazine Maroc Hebdo had a cover story entitled "the Black Peril," accusing sub-Saharan Africans of living off begging, drug trafficking and prostitution. The cover featured a close up shot of a black man's face. The …
Read more on News 10NBC
Novartis drug VotubiaR approved in the EU as first medication to treat …
Filed under: drug treatment news stories
Novartis International AG / Novartis drug VotubiaR approved in the EU as first medication to treat patients with non-cancerous kidney tumors associated with TSC . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for …
Read more on Reuters